Autoimmune Disease Testing Market Witnesses Shift Toward Home-Based Diagnostic Solutions
The global autoimmune disease testing market is on track for significant growth over the coming years. Estimated to be valued at approximately US$6.6 billion in 2025, the market is expected to surge to an impressive US$13.4 billion by 2032. This growth represents a compound annual growth rate (CAGR) of 10.8% from 2025 to 2032, signaling a substantial expansion in both demand and technological advancement in autoimmune disease diagnostics.